Viracta Therapeutics, Inc.
VIRX
$0.022
$0.005533.33%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.52% | -58.92% | -50.97% | -41.16% | -18.11% |
| Total Receivables | -- | -- | -- | -69.12% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -35.11% | -5.91% | -22.61% | -36.38% | -60.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -66.17% | -58.32% | -50.91% | -41.37% | -19.12% |
|
|
|||||
| Total Current Assets | -66.17% | -58.32% | -50.91% | -41.37% | -19.12% |
| Net Property, Plant & Equipment | -81.15% | -72.79% | -50.07% | 12.08% | 7.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -96.87% | -97.16% | -97.39% | -30.93% | -28.70% |
| Total Assets | -66.95% | -59.25% | -51.81% | -40.94% | -19.17% |
|
|
|||||
| Total Accounts Payable | -23.11% | -60.24% | 15.96% | -3.90% | 46.23% |
| Total Accrued Expenses | 15.77% | 17.21% | 27.48% | 44.25% | 15.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -33.84% | 301.43% | 646.22% | 9,092.81% | 6,661.90% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -21.56% | 88.33% | 159.58% | 283.31% | 288.08% |
|
|
|||||
| Total Current Liabilities | -21.56% | 88.33% | 159.58% | 283.31% | 288.08% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -21.56% | -20.58% | -12.73% | 9.99% | 153.23% |
|
|
|||||
| Common Stock & APIC | 4.35% | 2.59% | 2.89% | 2.99% | 3.62% |
| Retained Earnings | -17.17% | -18.92% | -21.13% | -23.76% | -23.28% |
| Treasury Stock & Other | 113.85% | 95.65% | 93.10% | 105.06% | 67.34% |
| Total Common Equity | -126.95% | -107.87% | -87.67% | -76.88% | -60.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -126.95% | -107.87% | -87.67% | -76.88% | -60.62% |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -122.05% | -93.45% | -78.32% | -70.02% | -55.75% |
|
|
|||||